Pluri Inc. (PLUR) stock
PLURNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30
$1.05−0.04 (-3.67%)
Close on Nov 13, 2026Market cap $12.96MP/E –Yield –
Pluri total assets
Total assets on the balance sheet at the end of each period.
Pluri's total assets was $24.93M at Sep 30, 2026. For fiscal 2026 it was $24.88M, down 35.7% from the year before. Over ten years it grew -5.9% a year on average. The highest annual figure on record is $93.54M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $24.88M | -35.7% |
| FY2025 | Jun 30, 2025 | $38.68M | -2.1% |
| FY2024 | Jun 30, 2024 | $39.53M | -22.2% |
| FY2023 | Jun 30, 2023 | $50.80M | -25.4% |
| FY2022 | Jun 30, 2022 | $68.07M | -27.2% |
| FY2021 | Jun 30, 2021 | $93.54M | +42.7% |
| FY2020 | Jun 30, 2020 | $65.53M | +109.3% |
| FY2019 | Jun 30, 2019 | $31.31M | -19.6% |
| FY2018 | Jun 30, 2018 | $38.96M | +3.8% |
| FY2017 | Jun 30, 2017 | $37.53M | -18.3% |
| FY2016 | Jun 30, 2016 | $45.94M | -32.6% |
| FY2015 | Jun 30, 2015 | $68.16M | -7.9% |
| FY2014 | Jun 30, 2014 | $74.02M | +8.4% |
| FY2013 | Jun 30, 2013 | $68.32M | +44.1% |
| FY2012 | Jun 30, 2012 | $47.42M | +3.1% |
| FY2011 | Jun 30, 2011 | $46.02M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Sep 30, 2026 | $24.93M | -26.0% |
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $24.88M | -35.7% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $26.06M | -30.3% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $30.60M | -0.9% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $33.67M | -5.0% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $38.68M | -2.1% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $37.41M | +2.8% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $30.86M | -25.8% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $35.44M | -20.4% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $39.53M | -22.2% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $36.39M | -35.3% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $41.56M | -30.6% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $44.54M | -25.5% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $50.80M | -25.4% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $56.24M | -28.9% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $59.93M | -26.2% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $59.75M | -28.6% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $68.07M | -27.2% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $79.13M | -0.1% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $81.18M | +55.3% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $83.75M | +42.1% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $93.54M | +42.7% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $79.17M | +243.9% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $52.26M | +110.2% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $58.95M | +113.8% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $65.53M | +109.3% |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $23.02M | +22.9% |
| Q2 FY2020CQ4 2019 | Dec 31, 2019 | $24.86M | +2.3% |
| Q1 FY2020CQ3 2019 | Sep 30, 2019 | $27.57M | -10.7% |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $31.31M | -19.6% |
| Q3 FY2019CQ1 2019 | Mar 31, 2019 | $18.73M | -56.4% |
| Q2 FY2019CQ4 2018 | Dec 31, 2018 | $24.30M | -45.7% |
| Q1 FY2019CQ3 2018 | Sep 30, 2018 | $30.89M | -0.2% |
| Q4 FY2018CQ2 2018 | Jun 30, 2018 | $38.96M | +3.8% |
| Q3 FY2018CQ1 2018 | Mar 31, 2018 | $42.97M | -1.3% |
| Q2 FY2018CQ4 2017 | Dec 31, 2017 | $44.73M | +38.5% |
| Q1 FY2018CQ3 2017 | Sep 30, 2017 | $30.95M | – |
| Q4 FY2017CQ2 2017 | Jun 30, 2017 | $37.53M | – |
| Q3 FY2017CQ1 2017 | Mar 31, 2017 | $43.54M | – |
| Q2 FY2017CQ4 2016 | Dec 31, 2016 | $32.30M | – |
See a number that looks wrong?